Antimicrobial activity of selected synbiotics targeted for the elderly against pathogenic Escherichia coli strains

International Journal of Food Sciences and Nutrition

Volumn 67, Issue 2, 2016, Pages 83-91

  Likotrafiti, E ^a   Tuohy, K M ^b   Gibson, G R ^c   Rastall, R A ^c  

^a ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

^b RESEARCH AND INNOVATION CENTRE   (Italy)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

Bifidobacterium; Gut model; Lactobacillus

Indexed keywords

PROBIOTIC AGENT; SYNBIOTIC AGENT;

AGED; ANTIBIOSIS; BIFIDOBACTERIUM LONGUM; COCULTURE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; FECES; HUMAN; LACTOBACILLUS FERMENTUM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY;

AGED; ANTIBIOSIS; BACTERIOLOGICAL TECHNIQUES; BIFIDOBACTERIUM LONGUM; COCULTURE TECHNIQUES; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; FECES; HUMANS; LACTOBACILLUS FERMENTUM; PROBIOTICS; SYNBIOTICS;

EID: 84964388595     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2015.1134444     Document Type: Article

References (33)

1. Beerens H. 1991. Detection of bifidobacteria by using propionic acid as a selective agent. Appl Environ Microbiol 57:2418-2419.
2. Bielecka M, Biedrzycka E, Majkowska A, Juśkiewicz J, Wróblewska M. 2002. Effect of non-digestible oligosaccharides on gut microecosystem in rats. Food Res Int 35:139-144.
3. Claesson MJ, Cusack S, O'sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, et al. 2011. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. PNAS 108:4586-4591.
4. Collins MD, Gibson GR. 1999. Probiotics, prebiotics and synbiotics: approaches for the nutritional modulation of microbial ecology. Am J Clin Nutr 69:1052-1057.
5. Cummings JH, Christie S, Cole TJ. 2001. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther 15:1139-1145.
6. de Waard R, Garssen J, Bokken GCAM, Vos JG. 2002. Antagonistic activity of Lactobacillus casei strain Shirota against gastrointestinal Listeria monocytogenes infection in rats. Int J Food Microbiol 73:93-100.
7. Eribo B, Ashenafi M. 2003. Behaviour of Escherichia coli O157 in tomato and processed tomato products. Food Res Int 36:823-830.
8. Gagnon M, Kheadr EE, Dabour N, Richard D, Fliss I. 2006. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Int J Food Microbiol 111:26-33.
9. Gibson GR. 2004. Fibre and effects on probiotics (the prebiotic concept). Clin Nutr Suppl 1:25-31.
10. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401-1412.
11. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A. 2010. Dietary prebiotics: current status and new definition. IFIS Funct Foods Bull 7:1-19.
12. Gibson GR, Wang X. 1994. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77:412-420.
13. Hébuterne X. 2003. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care 6:49-54.
14. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, et al. 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506-514.
15. Horwarth C. 2002. Nutrition and ageing. In: Mann J, Truswell AS, editors. Essentials of human nutrition. Oxford: Oxford University Press. p. 551-565.
16. Hudault S, Liévin V, Bernet-Camard M-F, Servin A. 1997. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 63:513-518.
17. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, et al. 1999. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65:4949-4956.
18. Kapiki A, Costalos C, Oikonomidou C, Triantafyllidou A, Loukatou E, Pertrohilou V. 2007. The effect of a fructooligosaccharide supplemented formula on gut flora of preterm infants. Early Hum Dev 83:335-339.
19. Lesourd B. 1999. Immune response during disease and recovery in the elderly. Proc Nutr Soc 58:85-98.
20. Likotrafiti E, Manderson KS, Fava F, Tuohy KM, Gibson GR, Rastall RA. 2004. Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly individuals. Microb Ecol Health Dis 16:105-112.
21. Likotrafiti E, Tuohy KM, Gibson GR, Rastall RA. 2013. Development of antimicrobial synbiotics using potentiallyprobiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum. Anaerobe 20:5-13.
22. Likotrafiti E, Tuohy KM, Gibson GR, Rastall RA. 2014. An in vitro study of the effect of probiotics, prebiotics and synbiotics on the elderly faecal microbiota. Anaerobe 27:50-55.
23. Macfarlane GT, Macfarlane S, Gibson GR. 1998. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 35:180-187.
24. Mikkelsen LL, Jakobsen M, Jensen BB. 2003. Effects of dietary oligosaccharides on microbial diversity and fructo-oligosaccharide degrading bacteria in.faeces of piglets post-weaning. Anim Feed Sci Technol 109:133-150.
25. Mitsou EK, Turunen K, Anapliotis P, Zisi D, Spiliotis V, Kyriacou A. 2009. Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota. Int J Food Microbiol 135:112-117.
26. Rycroft CE, Jones MR, Gibson GR, Rastall RA. 2001. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91:878-887.
27. Ryu J-H, Beuchat LR. 1998. Influence of acid tolerance responses on survival, growth, and thermal cross-protection of Escherichia coli O157:H7 in acidified media and fruit juices. Int J Food Microbiol 45:185-193.
28. Schoster A, Kokotovic B, Permin A, Pedersen PD, Dal Bello F, Guardabassi L. 2013. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe 20:36-41.
29. Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. 2013. The influence of diet on the gut microbiota. Pharmacol Res 69:52-60.
30. Shu Q, Gill HS. 2002. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 34:59-64.
31. Tejero-Sariñena S, Barlow J, Costabile A, Gibson GR, Rowland I. 2012. In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids. Anaerobe 18:530-538.
32. Tejero-Sariñena S, Barlow J, Costabile A, Gibson GR, Rowland I. 2013. Antipathogenic Activity of Probiotics Against Salmonella Typhimurium and Clostridium Difficile in Anaerobic Batch Culture Systems: Is It Due to Synergies in Probiotic Mixtures or the Specificity of Single Strains? Anaerobe 24:60-65.
33. Tiihonen K, Ouwehand AC, Rautonen N. 2009. Human intestinal microbiota and healthy ageing. Ageing Res Rev 9:107-116.